LIVI, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.096
EU - Europa 12.860
AS - Asia 4.630
SA - Sud America 245
OC - Oceania 192
AF - Africa 83
Continente sconosciuto - Info sul continente non disponibili 5
Totale 39.111
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.020
RU - Federazione Russa 4.690
PL - Polonia 2.694
IT - Italia 1.806
HK - Hong Kong 1.626
SG - Singapore 1.399
IE - Irlanda 1.311
SE - Svezia 1.045
CN - Cina 790
DE - Germania 315
FI - Finlandia 254
JO - Giordania 229
BR - Brasile 222
IN - India 219
GB - Regno Unito 193
AU - Australia 188
UA - Ucraina 180
ID - Indonesia 81
FR - Francia 75
CH - Svizzera 70
ES - Italia 70
CA - Canada 64
VN - Vietnam 62
KR - Corea 56
TR - Turchia 56
CI - Costa d'Avorio 52
NL - Olanda 44
BE - Belgio 38
CZ - Repubblica Ceca 22
JP - Giappone 15
IL - Israele 12
HU - Ungheria 11
LT - Lituania 9
UZ - Uzbekistan 9
IQ - Iraq 8
EG - Egitto 7
GR - Grecia 7
IR - Iran 7
PE - Perù 7
AT - Austria 6
AZ - Azerbaigian 6
KG - Kirghizistan 6
KZ - Kazakistan 6
MA - Marocco 6
AR - Argentina 5
BG - Bulgaria 5
EC - Ecuador 5
PK - Pakistan 5
SC - Seychelles 5
AE - Emirati Arabi Uniti 4
BD - Bangladesh 4
DK - Danimarca 4
EU - Europa 4
NZ - Nuova Zelanda 4
PH - Filippine 4
ZA - Sudafrica 4
CY - Cipro 3
DZ - Algeria 3
GE - Georgia 3
MX - Messico 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TW - Taiwan 3
DM - Dominica 2
DO - Repubblica Dominicana 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MU - Mauritius 2
PS - Palestinian Territory 2
RO - Romania 2
VE - Venezuela 2
AO - Angola 1
BH - Bahrain 1
CL - Cile 1
CO - Colombia 1
GT - Guatemala 1
JM - Giamaica 1
KH - Cambogia 1
LV - Lettonia 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TM - Turkmenistan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 39.111
Salva come PNG Salva come JPEG
Città #
Santa Clara 5.239
Warsaw 2.691
Fairfield 2.458
Chandler 1.357
Hong Kong 1.348
Dublin 1.309
Ashburn 1.246
Woodbridge 1.125
Seattle 1.065
Cambridge 974
Houston 920
Wilmington 796
Singapore 765
Lawrence 443
Altamura 420
Florence 416
Ann Arbor 413
Princeton 359
Jacksonville 280
Beijing 245
Buffalo 211
Boston 193
Melbourne 183
Moscow 179
Mumbai 169
Shanghai 159
Medford 156
Dearborn 155
San Diego 141
Boardman 136
New York 119
Kent 87
Jakarta 80
Milan 72
Los Angeles 66
Bern 61
Helsinki 59
Falls Church 57
Barcelona 55
Munich 55
Rome 53
Abidjan 52
Seoul 50
Izmir 45
Norwalk 44
Dong Ket 43
London 39
Brussels 36
Toronto 36
Guangzhou 34
Hillsboro 32
Yubileyny 32
Andover 27
Pune 27
West Jordan 27
Frankfurt am Main 24
Redwood City 24
Phoenix 21
São Paulo 21
Shenzhen 19
Lauterbourg 18
Brno 17
Nanjing 17
Portsmouth 17
Ottawa 16
Bologna 15
Prato 14
Salerno 14
Prad am Stilfser Joch 13
Örebro 13
Redmond 12
Verona 12
Paris 11
Kilburn 10
Wuhan 10
Tashkent 9
The Dalles 9
Campinas 8
Charlotte 8
Falkenstein 8
Rio de Janeiro 8
Turin 8
Auburn Hills 7
Bari 7
Brescia 7
Frankfurt Am Main 7
Hefei 7
Naples 7
Southwark 7
Tappahannock 7
Zurich 7
Bishkek 6
Brasília 6
Budapest 6
Castelliri 6
Chicago 6
Garden City 6
Hangzhou 6
Lappeenranta 6
Laurel 6
Totale 27.332
Salva come PNG Salva come JPEG
Nome #
Sodium hyaluronate and chondroitin sulfate replenishment therapy can improve nocturia in men with post-radiation cystitis: results of a prospective pilot study 288
Quality of Life and Sexual Health in the Aging of PCa Survivors. 288
Raccomandazioni cliniche per il carcinoma mammario 282
Intravesical hyaluronic acid and chondroitin sulfate (Ialuril™) replenishment therapy for postradiation cystitis of prostate cancer: Results of a prospective pilot study 263
Stereotactic body radiotherapy for cardiac and paracardiac metastases: University of Florence experience. 253
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. 251
Therapeutic usability of two different fiducial gold markers for robotic stereotactic radiosurgery of liver malignancies: A pilot study 250
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 245
Head and neck reconstruction with pedicled flaps in the free flap era. 242
Radiosensitivity in the breast cancer management scenario: Another step forward? 230
The Evolving Role of Ultrasound Guided Percutaneous Laser Ablation in Elderly Unresectable Breast Cancer Patients: A Feasibility Pilot Study 229
hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer. 227
Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study 224
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis 221
Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature. 220
Breast cancer occurred after Hodgkin's disease: Clinico-pathological features, treatments and outcome: Analysis of 214 cases. 220
Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy. 214
A multiparametric method to assess the MIM deformable image registration algorithm 210
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy inmetastatic breast cancer: a retrospective analysis. 208
Operator-dependent reproducibility of size measurements of small phantoms and lung nodules examined with low dose thin-section 206
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 202
In Regard to Vaidya et al 191
Prognosis of men with penile metastasis and malignant priapism: a systematic review. 190
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 186
Role of magnetic resonance imaging in the preoperative staging and work-up of patients affected by invasive lobular carcinoma or invasive ductolobular carcinoma 182
Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles 176
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab 170
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. 168
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial 167
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer 167
Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Results of a large single-institution series 165
ADAM: A breathing phantom for lung SBRT quality assurance 163
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 163
Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment 162
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 161
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures 161
ADAM phantom to test 4D medical imaging and dose delivery devices 159
Interim PET after Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 159
Influence of age and subtype in outcome of operable liposarcoma 157
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 156
Bladder Instillation Therapy With Hyaluronic Acid and Chondroitin Sulfate Improves Symptoms of Postradiation Cystitis: Prospective Pilot Study 155
Auto-planning for VMAT accelerated partial breast irradiation 155
Alternating intravenous and oral vinorelbine plus epirubicin with pegfilgrastim as neoadjuvant treatment of locally advanced breast cancer. 154
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 153
Oral Lapacho-Based Medication: An Easy, Safe, and Feasible Support to Prevent and/or Reduce Oral Mucositis during Radiotherapy for Head and Neck Cancer 153
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 152
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 152
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients 152
Current trends and outcomes of breast reconstruction following nipple-sparing mastectomy: results from a national multicentric registry with 1006 cases over a 6-year period 151
Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients. 150
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature 148
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 148
Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy 147
Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery. 146
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 146
CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed 146
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 145
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer 144
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 144
Cervicoisthmic choriocarcinoma mimicking cesarean section scar ectopic pregnancy 143
Role of core needle biopsy in primary breast lymphoma 143
Accelerated intensity-modulated external radiotherapy as a new technical approach to treat the index quadrant after conserving surgery in early breast cancer: a preliminary study. 143
Breast cancer in the elderly: treatment of 1500 patients. 142
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 142
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 142
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 142
Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy. 141
Uterine sarcoma: twenty-seven years of experience. 141
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 141
Use of tamoxifen in pT1a-pT1b, pN0 breast cancer. 141
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 140
Radiotherapy in the age of cancer immunology: Current concepts and future developments 139
Docetaxel in Castration-Resistant Prostate Cancer: A Single-Centre Experience 138
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 137
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 137
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 137
Stage I seminoma of the testis: a bi-institutional retrospective analysis of patients treated with radiation therapy only 135
Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series 135
Late treatment-related complications in 214 patients with extremity soft-tissue sarcoma treated by surgery and postoperative radiation therapy. 135
Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer 135
Priapism due to sacrococcygeal chordoma metastasis treated with radiation therapy 134
Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma. 134
Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment. 133
Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer. 133
Localized prostate cancer treated with intensity-modulated radiotherapy. 133
Radiation therapy of ocular melanoma: pre-clinical experience 133
Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen. 133
Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node 133
Adjuvant trastuzumab in breast cancer: experience from the University of Florence. 132
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 131
Renal cell carcinoma metastatic to the breast and breast cancer metastatic to the kidney: two rare solitary metastases. 130
Doxorubicin and cyclophosphamideversus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvantchemotherapy in breast cancer. 130
ADAM: A 3D printed breathing phantom for end to end tests on RT treatments 130
Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab expanded access program (EAP) in Italy 130
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 130
91P * DEFINITIVE CONCOMITANT RADIOCHEMOTHERAPY (RCT) TREATMENT FOR LOCALLY ADVANCED (LA) NON SMALL CELL LUNG CANCER (NSCLC): EVALUATION OF HEMATOLOGICAL AND ESOPHAGEAL TOXICITY IN THE RADIATION ONCOLOGY DEPARTMENT OF UNIVERSITY OF FLORENCE EXPERIENCE 130
Cancer stem cells: biology and potential therapeutic applications 129
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 129
Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 Patients treated with a prospective margin-directed policy 128
Ribociclib plus letrozole and concomitant palliative radiotherapy for metastatic breast cancer 128
Totale 16.569
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.156
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.156
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.577 0 0 0 0 0 0 0 0 619 396 421 141
2020/20213.130 272 260 163 425 164 277 187 226 311 428 233 184
2021/20222.233 58 175 189 130 71 111 83 198 98 111 390 619
2022/20236.166 565 1.252 262 348 451 1.051 775 414 685 63 170 130
2023/20242.592 109 252 368 137 166 365 116 581 53 134 206 105
2024/202515.044 623 1.685 1.048 2.739 4.892 1.977 304 985 791 0 0 0
Totale 39.580